Background
Methods
Data source
Participants and sample selection
Statistical analysis
Results
n = 4275 | N = 295,525 | |
---|---|---|
Variable | Mean ± SD/Count (%) | Mean ± SD/Count (%) |
Age | 73.7 ± 9.2 | 71.1 ± 9.8 |
Race | ||
White | 3001 (70.2) | 208,702 (70.6) |
Black | 553 (12.9) | 33,282 (11.3) |
Hispanic | 324 (7.6) | 23,328 (7.9) |
Asian | 84 (2.0) | 6144 (2.1) |
Unknown | 313 (7.3) | 24,069 (8.1) |
Education level | ||
Less than 12th grade | 32 (0.7) | 1681 (0.6) |
High school diploma | 1223 (28.6) | 82,070 (27.8) |
Less than bachelor degree | 2238 (52.4) | 153,094 (51.8) |
Bachelor degree plus | 599 (14.0) | 42,997 (14.5) |
Unknown | 183 (4.3) | 15,683 (5.3) |
Household income range | ||
< 50 k | 1544 (36.1) | 93,629 (31.7) |
50 k-99 k | 1312 (30.7) | 90,934 (30.8) |
> 100 k | 837 (19.6) | 70,373 (23.8) |
Unknown | 582 (13.6) | 40,589 (13.7) |
Geographic Region* | ||
New England | 203 (4.7) | 15,488 (5.2) |
Middle Atlantic | 299 (7.0) | 25,371 (8.6) |
South Atlantic | 950 (22.2) | 71,420 (24.2) |
East North Central | 567 (13.3) | 38,633 (13.1) |
East South Central | 131 (3.1) | 9677 (3.3) |
West North Central | 448 (10.5) | 27,567 (9.3) |
West South Central | 421 (9.8) | 27,438 (9.3) |
Mountain | 441 (10.3) | 27,673 (9.4) |
Pacific | 628 (14.7) | 35,722 (12.1) |
Unknown | 187 (4.4) | 16,536 (5.6) |
Product | ||
HMO | 2079 (48.6) | 121,353 (41.1) |
PPO | 547 (12.8) | 39,180 (13.3) |
Other | 1649 (38.6) | 134,955 (45.7) |
Unknown | 0 (0.0) | 37 (0.0) |
Metastatic | ||
Yes | 3446 (80.6) | 17,802 (6.0) |
No | 829 (19.4) | 277,723 (94.0) |
Therapy/Year | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | All |
---|---|---|---|---|---|---|---|
Docetaxel | 374 | 434 | 391 | 207 | 255 | 137 | 1798 |
97.1% | 66.0% | 48.9% | 22.6% | 24.4% | 29.0% | 42.1% | |
(95.0, 98.4) | (62.3, 69.5) | (45.4, 52.3) | (20.1, 25.5) | (21.9, 27.1) | (25.1, 33.2) | (40.6, 43.5) | |
Cabazitaxel | 7 | 9 | 7 | 3 | 4 | 3 | 33 |
1.8% | 1.4% | 0.9% | 0.3% | 0.4% | 0.6% | 0.8% | |
(0.9, 3.7) | (0.7, 2.6) | (0.4, 1.8) | (0.1, 1.0) | (0.1, 1.0) | (0.2, 1.8) | (0.6, 1.1) | |
Sipuleucel-T | 4 | 54 | 120 | 110 | 98 | 30 | 416 |
1.0% | 8.2% | 15.0% | 12.0% | 9.4% | 6.3% | 9.7% | |
(0.4, 2.6) | (6.3, 10.6) | (2.7, 17.6) | (10.1, 14.3) | (7.8, 11.3) | (4.5, 8.9) | (8.9, 10.7) | |
Radium-223 | 0 | 0 | 0 | 2 | 12 | 18 | 32 |
0.0% | 0.0% | 0.0% | 0.2% | 1.1% | 3.8% | 0.7% | |
(0.0, 1.0) | (0.0, 0.6) | (0.0, 0.5) | (0.1, 0.8) | (0.7, 2.0) | (2.4, 5.9) | (0.5, 1.1) | |
Abiraterone | 0 | 161 | 254 | 515 | 479 | 162 | 1571 |
0.0% | 24.5% | 31.8% | 56.3% | 45.8% | 34.2% | 36.7% | |
(0.0, 1.0) | (21.3, 27.9) | (28.6, 35.1) | (53.1, 59.5) | (42.8, 48.9) | (30.1, 38.6) | (35.3, 38.2) | |
Enzalutamide | 0 | 0 | 28 | 77 | 197 | 123 | 425 |
0.0% | 0.0% | 3.5% | 8.4% | 18.9% | 26.0% | 9.9% | |
(0.0, 1.0) | (0.0, 0.6) | (2.4, 5.0) | (6.8, 10.4) | (16.6, 21.3) | (22.3, 30.1) | (9.1, 10.9) | |
Total
| 385 | 658 | 800 | 914 | 1045 | 473 | 4275 |
Region | Docetaxel (%) | Cabazitaxel (%) | Sipuleucel-T (%) | Radium-223 (%) | Abiraterone (%) | Enzalutamide (%) | Row Total |
---|---|---|---|---|---|---|---|
New England | 12 (27.3) | 0 (0.0) | 3 (6.8) | 0 (0.0) | 22 (50.0) | 7 (15.9) | 44 |
11 | 0 | 4 | 1 | 20 | 8 | ||
Middle Atlantic | 23 (21.5) | 0 (0.0) | 6 (5.6) | 3 (2.8) | 50 (46.7) | 25 (23.4) | 107 |
26 | 0 | 10 | 1 | 50 | 20 | ||
South Atlantic | 44 (26.0) | 0 (0.0) | 20 (11.8) | 2 (1.2) | 70 (41.4) | 33 (19.5) | 169 |
41 | 0 | 16 | 2 | 78 | 32 | ||
East North Central | 38 (22.0) | 3 (1.7) | 17 (9.8) | 2 (1.2) | 73 (42.2) | 40 (23.1) | 173 |
42 | 0 | 16 | 2 | 79 | 33 | ||
East South Central | 5 (14.7) | 0 (0.0) | 4 (11.8) | 0 (0.0) | 19 (55.9) | 6 (17.6) | 34 |
8 | 0 | 3 | 0 | 16 | 6 | ||
West North Central | 39 (45.3) | 0 (0.0) | 12 (14.0) | 3 (3.5) | 23 (26.7) | 9 (10.5) | 86 |
21 | 0 | 8 | 1 | 39 | 16 | ||
West South Central | 20 (21.1) | 0 (0.0) | 9 (9.5) | 1 (1.1) | 46 (48.4) | 19 (20.0) | 95 |
23 | 0 | 9 | 1 | 44 | 18 | ||
Mountain | 26 (21.1) | 0 (0.0) | 13 (10.6) | 0 (0.0) | 64 (52.0) | 20 (16.3) | 123 |
30 | 1 | 12 | 1 | 56 | 23 | ||
Pacific | 23 (15.6) | 0 (0.0) | 5 (3.4) | 0 (0.0) | 91 (61.9) | 28 (19.0) | 147 |
36 | 1 | 14 | 2 | 67 | 28 | ||
Unknown | 25 (37.3) | 1 (1.5) | 9 (13.4) | 1 (1.5) | 21 (31.3) | 10 (14.9) | 67 |
16 | 0 | 6 | 1 | 31 | 13 | ||
Column Total | 255 | 4 | 98 | 12 | 479 | 197 | 1045 |